dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Abdel-Mannan, Omar |
dc.contributor.author | Manchoon, Celeste |
dc.contributor.author | Rossor, Thomas |
dc.contributor.author | Southin, Justine-Clair |
dc.contributor.author | TUR, CARMEN |
dc.contributor.author | Brownlee, Wallace |
dc.date.accessioned | 2022-01-11T13:28:56Z |
dc.date.available | 2022-01-11T13:28:56Z |
dc.date.issued | 2021-07 |
dc.identifier.citation | Abdel-mannan OA, Manchoon C, Rossor T, Southin JC, Tur C, Brownlee W, et al. Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom. Neurol Neuroimmunol Neuroinflamm. 2021 Jul;8(4):e1008. |
dc.identifier.issn | 2332-7812 |
dc.identifier.uri | https://hdl.handle.net/11351/6762 |
dc.description | Esclerosi múltiple; Ressonància magnètica |
dc.description.sponsorship | O.A. Abdel-Mannan is funded by a Guarantors of Brain Clinical Entry Fellowship. C. Hemingway is funded by an MRC Clinical Academic Research Partnership grant (MR/T024437/1). Y. Hacohen is funded by the UK MS society. O. Ciccarelli is NIHR Research Professor (Round 8). |
dc.language.iso | eng |
dc.publisher | Lippincott Williams & Wilkins |
dc.relation.ispartofseries | Neurology-Neuroimmunology & Neuroinflammation;8(4) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Esclerosi múltiple - Tractament |
dc.subject | Infants |
dc.subject.mesh | Multiple Sclerosis |
dc.subject.mesh | /therapy |
dc.subject.mesh | Child |
dc.title | Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1212/NXI.0000000000001008 |
dc.subject.decs | esclerosis múltiple |
dc.subject.decs | /terapia |
dc.subject.decs | niño |
dc.relation.publishversion | https://doi.org/10.1212/NXI.0000000000001008 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Abdel-Mannan OA] Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London; Department of Neurology, Great Ormond Street Hospital for Children, London, United Kingdom. [Manchoon C] Children’s Neurosciences, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation, United Kingdom. [Rossor T] Children’s Neurosciences, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation, United Kingdom. [Southin JC] Department of Neurology, Alder Hey Children’s NHS Foundation Trust, Liverpool, United Kingdom. [Tur C] Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Brownlee W] Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, United Kingdom |
dc.identifier.pmid | 34021056 |
dc.identifier.wos | 000711800300018 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |